This is the first human cancer vaccine study to see T-cell responses in the absence of B cells, and this paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B cells.

162

This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B cells.

109